版本:
中国

BRIEF-Aeterna Zentaris qtrly loss per share $0.31

May 8 Aeterna Zentaris Inc:

* Aeterna Zentaris reports first quarter 2017 financial and operating results

* Aeterna Zentaris Inc - qtrly revenue $261,000 versus $242,000; qtrly loss per share $0.31

* Aeterna Zentaris Inc - do not anticipate conducting clinical trials of zoptrex with respect to any other indications

* Aeterna Zentaris Inc - co's focus has now shifted entirely to filing new drug application for macrilen Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐